J&J Medical Connect
TALVEY®

(talquetamab-tgvs)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

TALVEY® (talquetamab-tgvs)
Medical Information

TALVEY - Preparation and Administration Using Aseptic Technique in Clinical Trials

Last Updated: 06/30/2026

Summary

  • Aseptic technique must be used to prepare and administer TALVEY.1
  • In clinical trials, TALVEY was prepared using aseptic technique. It was preferred that the preparation of the product be performed under a laminar flow hood (LFH) or biological safety cabinet (BSC).1

Literature Search

A literature search of MEDLINE®, Embase®, BIOSIS Previews®, and Derwent Drug File databases (and/or other resources, including internal/external databases) was conducted on 30 June 2026.

References

Show
1 Data on File. Talquetamab. Investigational product preparation and administration instruction for subcutaneous administration of 2 mg/mL (3 mg) and 40 mg/mL (40 mg). Janssen Research and Development, LLC. TV-TEC-207195; version 5.0; 2024.  

Would you like to clear and leave your conversation? Message history will be lost.